D. Ross Camidge
MD, PhD
Professor of Medicine and Director of Thoracic Oncology
👥Biography 个人简介
Dr. D. Ross Camidge is a leading thoracic oncologist who has contributed substantially to MET-targeted therapy in lung cancer. He participated in pivotal studies of tepotinib and capmatinib in METex14 and MET-amplified NSCLC and has investigated MET amplification as both a primary driver and an acquired resistance mechanism. His expertise spans the spectrum of rare driver oncogenes in NSCLC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 D. Ross Camidge 的研究动态
Follow D. Ross Camidge's research updates
留下邮箱，当我们发布与 D. Ross Camidge（University of Colorado Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment